Voluntary Faculty
Voluntary faculty are typically clinicians or others who are employed outside of the School but make significant contributions to department programs at the medical center or at affiliate institutions.
Voluntary rank detailsDavid Jaihun Byun, MD
Clinical InstructorAbout
Research
Publications
2026
Curietherapy User eXperience Pilot Study (CurieUx): A Feasibility Study of a Novel Augmented Reality Educational Tool During Radiation Oncology Consultation for Patients With Breast Cancer
Byun D, Liu E, Maisonet O, Xiao J, Du K, Gerber N. Curietherapy User eXperience Pilot Study (CurieUx): A Feasibility Study of a Novel Augmented Reality Educational Tool During Radiation Oncology Consultation for Patients With Breast Cancer. International Journal Of Radiation Oncology • Biology • Physics 2026, 125: 1094-1100. PMID: 41539575, DOI: 10.1016/j.ijrobp.2025.12.057.Peer-Reviewed Original Research
2025
Feasibility of combining high-dose-rate prostate brachytherapy with dose intensification to the MRI dominant lesion followed by real-time adaptive MR-guided pelvic radiotherapy for high-risk prostate cancer
Cohen G, Gurewitz J, Johnson J, Cooney J, Shi Y, Adler H, Long M, Byun D, Zelefsky M. Feasibility of combining high-dose-rate prostate brachytherapy with dose intensification to the MRI dominant lesion followed by real-time adaptive MR-guided pelvic radiotherapy for high-risk prostate cancer. Brachytherapy 2025, 25: 235-240. PMID: 41242924, DOI: 10.1016/j.brachy.2025.10.013.Peer-Reviewed Original ResearchDose Intensification to the Dominant Intraprostatic Lesion During Prostate Stereotactic Body Radiation Therapy Delivered on a Magnetic Resonance Imaging Linear Accelerator: Feasibility and Early Clinical Outcomes
Zelefsky M, Byun D, Long M, Fuligni G, Wang H, Lu S, Chen T, Barbee D. Dose Intensification to the Dominant Intraprostatic Lesion During Prostate Stereotactic Body Radiation Therapy Delivered on a Magnetic Resonance Imaging Linear Accelerator: Feasibility and Early Clinical Outcomes. Advances In Radiation Oncology 2025, 10: 101905. PMID: 41216206, PMCID: PMC12596952, DOI: 10.1016/j.adro.2025.101905.Peer-Reviewed Original ResearchChanges in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity
Gurewitz J, Oh C, Woo S, Kim J, Bruzzese A, Chen T, Wang H, Byun D, Zelefsky M. Changes in prostate volume during prostate SBRT delivered on an MR-Linac and correlation with acute toxicity. Clinical And Translational Radiation Oncology 2025, 54: 101007. PMID: 40677622, PMCID: PMC12269632, DOI: 10.1016/j.ctro.2025.101007.Peer-Reviewed Original ResearchBladder filling dynamics during online adaptive prostate stereotactic body radiotherapy: Rationale for using an empty bladder workflow for treatment
Byun D, Oh C, Kim J, Barbee D, Long M, Fuligni G, Chen T, Wang H, Lu S, Zelefsky M. Bladder filling dynamics during online adaptive prostate stereotactic body radiotherapy: Rationale for using an empty bladder workflow for treatment. Radiotherapy And Oncology 2025, 209: 110978. PMID: 40466739, DOI: 10.1016/j.radonc.2025.110978.Peer-Reviewed Original ResearchLow incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center
Woo S, Becker A, Katz A, Tong A, Vargas H, Byun D, Lischalk J, Haas J, Zelefsky M. Low incidence of significant hydrogel spacer rectal wall infiltration: results from an experienced high-volume center. Frontiers In Oncology 2025, 15: 1563015. PMID: 40098707, PMCID: PMC11911376, DOI: 10.3389/fonc.2025.1563015.Peer-Reviewed Original Research
2024
Commissioning and implementation of a pencil‐beam algorithm with a Lorentz correction as a secondary dose calculation algorithm for an Elekta Unity 1.5T MR linear accelerator
Taneja S, Wang H, Barbee D, Galavis P, Sosa M, Byun D, Zelefsky M, Chen T. Commissioning and implementation of a pencil‐beam algorithm with a Lorentz correction as a secondary dose calculation algorithm for an Elekta Unity 1.5T MR linear accelerator. Journal Of Applied Clinical Medical Physics 2024, 26: e14590. PMID: 39625056, PMCID: PMC11905237, DOI: 10.1002/acm2.14590.Peer-Reviewed Original Research
2023
Risk and Prognostics of Second Primary Cancer After Prostate Radiation Therapy
Liu E, Daniels T, Lischalk J, Oh C, Haas J, Evans A, Byun D. Risk and Prognostics of Second Primary Cancer After Prostate Radiation Therapy. Urology Practice 2023, 11: 146-152. PMID: 37917577, DOI: 10.1097/upj.0000000000000479.Peer-Reviewed Original ResearchA Tool to Integrate Electrophysiological Mapping for Cardiac Radioablation of Ventricular Tachycardia
Wang H, Barbhaiya C, Yuan Y, Barbee D, Chen T, Axel L, Chinitz L, Evans A, Byun D. A Tool to Integrate Electrophysiological Mapping for Cardiac Radioablation of Ventricular Tachycardia. Advances In Radiation Oncology 2023, 8: 101272. PMID: 37415904, PMCID: PMC10320498, DOI: 10.1016/j.adro.2023.101272.Peer-Reviewed Original Research
2022
Pulmonary Toxic Effects After Myeloablative Conditioning With Total Body Irradiation Delivered via Volumetric Modulated Arc Therapy With Fludarabine
Modrek A, Karp J, Byun D, Gerber N, Abdul-Hay M, Al-Homsi A, Galavis P, Teruel J, Yuan Y. Pulmonary Toxic Effects After Myeloablative Conditioning With Total Body Irradiation Delivered via Volumetric Modulated Arc Therapy With Fludarabine. Practical Radiation Oncology 2022, 12: e476-e480. PMID: 35598860, DOI: 10.1016/j.prro.2022.05.003.Peer-Reviewed Original Research